Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medical devices
microbiome
national
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
opioids
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
synlogic
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
abeona therapeutics
What
bio
roundup
advantages
august
bar
biotech
brings
busy
days
decisions
devices
drug
drugs
expect
fda
gamble
legacy
market
medco’s
mover
new
news
nods
opioid
past
patients
payers
physicians
plan
pricing
regulatory
sarepta’s
sets
seven
shkreli’s
slow
stumble
suits
tends
type
Language
unset
Current search:
synlogic
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
